OBJ 4.76% 2.0¢ obj limited

Pfizer

  1. 2,367 Posts.
    lightbulb Created with Sketch. 9
    Pfizer's revenue is down again due to patent loss. Delivering these blockbuster drugs transdermally is a win for us, Pfizer, and more importantly, the patient.
 
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.